FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386266952> ?p ?o ?g. }

• W4386266952 endingPage "101769" @default.
• W4386266952 startingPage "101769" @default.
• W4386266952 abstract "Previous case studies have provided evidence for chemotherapy-induced leukoencephalopathy in patients with breast cancer. However, prospective research is lacking. Hence, we investigated leukoencephalopathy before and after chemotherapy and its association with a serum neuroaxonal damage marker.This prospective cohort study included 40 patients receiving chemotherapy for breast cancer, and two age- and education-matched control groups, recruited between 2018 and 2021 (31-64 years of age). The latter control groups consisted of 39 chemotherapy-naïve patients and 40 healthy women. Fluid-attenuated inversion-recovery magnetic resonance imaging was used for lesion volumetry (total, juxtacortical, periventricular, infratentorial, and deep white matter) and blood serum to measure neurofilament light chain (NfL) levels. Acquisition took place pre-chemotherapy and three months and one-year post-chemotherapy, or at corresponding intervals. Within/between group differences were compared using robust mixed-effects modeling, and associations between total lesion volume and serum-NfL with linear regression.Stronger increases in deep white matter lesion volumes were observed shortly post-chemotherapy, compared with healthy women (ßstandardized=0.09, pFDR<0.001). Increases in total lesion volume could mainly be attributed to enlargement of existing lesions (mean±SD, 0.12±0.16 mL), rather than development of new lesions (0.02±0.02 mL). A stronger increase in serum-NfL concentration was observed shortly post-chemotherapy compared with both control groups (ß>0.70, p<0.004), neither of which showed any changes over time, whereas a decrease was observed compared with healthy women one-year post-chemotherapy (ß=-0.54, p = 0.002). Serum-NfL concentrations were associated with lesion volume one-year post-chemotherapy (or at matched timepoint; ß=0.36, p = 0.010), whereas baseline or short-term post-therapy levels or changes were not.These results underscore the possibility of chemotherapy-induced leukoencephalopathy months post-treatment, as well as the added value of serum-NfL as a prognostic marker for peripheral/central neurotoxicity.Previous case studies have provided evidence of chemotherapy-induced leukoencephalopathy in patients with breast cancer. However, prospective studies to estimate longitudinal changes are currently missing. In this study, we used longitudinal fluid-attenuated inversion-recovery magnetic resonance imaging to assess white matter lesion volumes in patients treated for non-metastatic breast cancer and healthy women. Our findings demonstrate that chemotherapy-treated patients exhibit stronger increases in lesion volumes compared with healthy women, specifically in deep white matter, at three months post-chemotherapy. Increases could mainly be attributed to enlargement of existing lesions, rather than development of new lesions. Last, serum concentrations of neurofilament light chain, a neuroaxonal damage marker, increased shortly after chemotherapy and long-term post-chemotherapy levels were associated with lesion volumes. These findings highlight the potential of this non-invasive serum marker as a prognostic marker for peripheral and/or central neurotoxicity. Implementation in clinical practice could aid in therapeutic decisions, assessing disease activity, or monitoring treatment response." @default.
• W4386266952 created "2023-08-30" @default.
• W4386266952 creator A5000110993 @default.
• W4386266952 creator A5005962158 @default.
• W4386266952 creator A5014840717 @default.
• W4386266952 creator A5022005227 @default.
• W4386266952 creator A5055157144 @default.
• W4386266952 creator A5057980814 @default.
• W4386266952 creator A5089548339 @default.
• W4386266952 creator A5090263974 @default.
• W4386266952 creator A5092714484 @default.
• W4386266952 date "2023-11-01" @default.
• W4386266952 modified "2023-09-27" @default.
• W4386266952 title "Changes in leukoencephalopathy and serum neurofilament after (neo)adjuvant chemotherapy for breast cancer" @default.
• W4386266952 cites W1979327324 @default.
• W4386266952 cites W1991699276 @default.
• W4386266952 cites W2029629969 @default.
• W4386266952 cites W2032628622 @default.
• W4386266952 cites W2043989982 @default.
• W4386266952 cites W2098192159 @default.
• W4386266952 cites W2120068633 @default.
• W4386266952 cites W2142864721 @default.
• W4386266952 cites W2147580588 @default.
• W4386266952 cites W2157203036 @default.
• W4386266952 cites W2548008871 @default.
• W4386266952 cites W2560339715 @default.
• W4386266952 cites W2593792231 @default.
• W4386266952 cites W2595489545 @default.
• W4386266952 cites W2612214304 @default.
• W4386266952 cites W2777074421 @default.
• W4386266952 cites W2782831523 @default.
• W4386266952 cites W2783746308 @default.
• W4386266952 cites W2803973904 @default.
• W4386266952 cites W2804493020 @default.
• W4386266952 cites W2896236013 @default.
• W4386266952 cites W2903050755 @default.
• W4386266952 cites W2908373864 @default.
• W4386266952 cites W2912573533 @default.
• W4386266952 cites W2914396477 @default.
• W4386266952 cites W2940387119 @default.
• W4386266952 cites W3003348160 @default.
• W4386266952 cites W3021777890 @default.
• W4386266952 cites W3024239323 @default.
• W4386266952 cites W3043680095 @default.
• W4386266952 cites W3049635306 @default.
• W4386266952 cites W3083025044 @default.
• W4386266952 cites W3127416942 @default.
• W4386266952 cites W3128646645 @default.
• W4386266952 cites W3134785806 @default.
• W4386266952 cites W3167068736 @default.
• W4386266952 cites W3167450498 @default.
• W4386266952 cites W3194553885 @default.
• W4386266952 cites W3203920464 @default.
• W4386266952 cites W4200387539 @default.
• W4386266952 cites W4210446393 @default.
• W4386266952 cites W4210619744 @default.
• W4386266952 cites W4211123279 @default.
• W4386266952 cites W4224061283 @default.
• W4386266952 cites W4295242129 @default.
• W4386266952 doi "https://doi.org/10.1016/j.tranon.2023.101769" @default.
• W4386266952 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37651891" @default.
• W4386266952 hasPublicationYear "2023" @default.
• W4386266952 type Work @default.
• W4386266952 citedByCount "0" @default.
• W4386266952 crossrefType "journal-article" @default.
• W4386266952 hasAuthorship W4386266952A5000110993 @default.
• W4386266952 hasAuthorship W4386266952A5005962158 @default.
• W4386266952 hasAuthorship W4386266952A5014840717 @default.
• W4386266952 hasAuthorship W4386266952A5022005227 @default.
• W4386266952 hasAuthorship W4386266952A5055157144 @default.
• W4386266952 hasAuthorship W4386266952A5057980814 @default.
• W4386266952 hasAuthorship W4386266952A5089548339 @default.
• W4386266952 hasAuthorship W4386266952A5090263974 @default.
• W4386266952 hasAuthorship W4386266952A5092714484 @default.
• W4386266952 hasBestOaLocation W43862669521 @default.
• W4386266952 hasConcept C121608353 @default.
• W4386266952 hasConcept C126322002 @default.
• W4386266952 hasConcept C126838900 @default.
• W4386266952 hasConcept C142724271 @default.
• W4386266952 hasConcept C143409427 @default.
• W4386266952 hasConcept C143998085 @default.
• W4386266952 hasConcept C188816634 @default.
• W4386266952 hasConcept C2776694085 @default.
• W4386266952 hasConcept C2778583010 @default.
• W4386266952 hasConcept C2781156865 @default.
• W4386266952 hasConcept C2781192897 @default.
• W4386266952 hasConcept C530470458 @default.
• W4386266952 hasConcept C71924100 @default.
• W4386266952 hasConcept C90924648 @default.
• W4386266952 hasConceptScore W4386266952C121608353 @default.
• W4386266952 hasConceptScore W4386266952C126322002 @default.
• W4386266952 hasConceptScore W4386266952C126838900 @default.
• W4386266952 hasConceptScore W4386266952C142724271 @default.
• W4386266952 hasConceptScore W4386266952C143409427 @default.
• W4386266952 hasConceptScore W4386266952C143998085 @default.
• W4386266952 hasConceptScore W4386266952C188816634 @default.
• W4386266952 hasConceptScore W4386266952C2776694085 @default.
• W4386266952 hasConceptScore W4386266952C2778583010 @default.

• next